BioCentury
ARTICLE | Clinical News

T-SPOT: Pivotal trial started

June 29, 2015 7:00 AM UTC

Oxford Immunotec began the pivotal REACT trial of T-SPOT.CMV in up to 200 patients seropositive for CMV infection who are undergoing an allogeneic hematopoietic stem cell transplantation (HSCT). ...